These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 2643933

  • 1. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR, Perel JM.
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [Abstract] [Full Text] [Related]

  • 2. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks.
    Mavissakalian M, Perel J, Bowler K, Dealy R.
    Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792
    [Abstract] [Full Text] [Related]

  • 3. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR, Perel JM.
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [Abstract] [Full Text] [Related]

  • 4. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
    Mavissakalian M.
    J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493
    [Abstract] [Full Text] [Related]

  • 5. Imipramine in the treatment of agoraphobia: dose-response relationships.
    Mavissakalian M, Perel J.
    Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987
    [Abstract] [Full Text] [Related]

  • 6. A naturalistic study of imipramine in panic disorder and agoraphobia.
    Aronson TA.
    Am J Psychiatry; 1987 Aug; 144(8):1014-9. PubMed ID: 3300374
    [Abstract] [Full Text] [Related]

  • 7. The placebo effect in agoraphobia.
    Mavissakalian M.
    J Nerv Ment Dis; 1987 Feb; 175(2):95-9. PubMed ID: 2879882
    [Abstract] [Full Text] [Related]

  • 8. Is buspirone effective for panic disorder?
    Sheehan DV, Raj AB, Sheehan KH, Soto S.
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [Abstract] [Full Text] [Related]

  • 9. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J, Vallejo J.
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [Abstract] [Full Text] [Related]

  • 11. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR, Perel JM, Talbott-Green M, Sloan C.
    Biol Psychiatry; 1998 Jun 01; 43(11):848-54. PubMed ID: 9611676
    [Abstract] [Full Text] [Related]

  • 12. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R, Anderson DJ, Clancy J, Crowe RR, Slymen DJ, Ghoneim MM, Hinrichs JV.
    Arch Gen Psychiatry; 1984 Mar 01; 41(3):287-92. PubMed ID: 6367691
    [Abstract] [Full Text] [Related]

  • 13. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 Mar 01; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 14. Plasma levels of tricyclic antidepressants in panic disorder.
    Sweeney DR, Gold MS, Pottash AL, Martin D.
    Int J Psychiatry Med; 1986 Mar 01; 13(2):93-6. PubMed ID: 6642878
    [Abstract] [Full Text] [Related]

  • 15. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo.
    Zitrin CM, Klein DF, Woerner MG, Ross DC.
    Arch Gen Psychiatry; 1983 Feb 01; 40(2):125-38. PubMed ID: 6337578
    [Abstract] [Full Text] [Related]

  • 16. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M, Michelson L.
    J Clin Psychiatry; 1986 Mar 01; 47(3):117-22. PubMed ID: 3512534
    [Abstract] [Full Text] [Related]

  • 17. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M, Perel JM, Michelson L.
    J Clin Psychopharmacol; 1984 Feb 01; 4(1):36-40. PubMed ID: 6693582
    [Abstract] [Full Text] [Related]

  • 18. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
    Evans L, Kenardy J, Schneider P, Hoey H.
    Acta Psychiatr Scand; 1986 Jan 01; 73(1):49-53. PubMed ID: 2938422
    [Abstract] [Full Text] [Related]

  • 19. Initial depression and response to imipramine in agoraphobia.
    Mavissakalian M.
    J Nerv Ment Dis; 1987 Jun 01; 175(6):358-61. PubMed ID: 3295112
    [Abstract] [Full Text] [Related]

  • 20. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
    Klein DF, Ross DC, Cohen P.
    Arch Gen Psychiatry; 1987 Apr 01; 44(4):377-85. PubMed ID: 2882736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.